Skip to main content

Becton Dickinson Value Stock - Dividend - Research Selection

Becton dickinson

ISIN: US0758871091 , WKN: 857675

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and other products for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laparoscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women\'s health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Best Dividend Kings: April 2026

2026-04-24
Dividend Kings beat SPY YTD. See which are undervalued with 10%+ expected returns using Dividend Yield Theory, plus dividend growth trends—read now.

Becton Dickinson at 13x Earnings: MedTech's Most Mispriced Compounder

2026-04-24
A leaner, pure-play MedTech leader emerges from the Waters spin-off with a 25% operating margin

Becton Dickinson and Company (BDX): Gold Standard Defensive Stock

2026-04-24
We just covered the 14 Best Defensive Stocks to Invest In Now and Becton, Dickinson and Company (NYSE:BDX) ranks 8th on this list. Becton, Dickinson and Company (NYSE:BDX) is called a gold standard defensive stock. While some medical tech firms are volatile due to elective surgery trends, the firm is the primary global supplier of […]

West Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat Estimates

2026-04-23
West Pharmaceutical (WST) delivered earnings and revenue surprises of +27.00% and +8.55%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

$10+ Bn Microbiology Testing Market Analysis by Product, Technology, End User - Global Forecast to 2031

2026-04-22
The global microbiology testing market is set to reach USD 10.09 billion by 2031, growing from USD 7.79 billion in 2026 at a CAGR of 5.3%. Growth is driven by rising contamination risks in food, water, and environmental sectors, along with advances in testing technologies. Pharmaceutical & biotech companies dominate the market due to stringent regulations for contamination control and product safety. The bacterial products segment holds the largest share, necessitating continual bacterial testin

Zacks Industry Outlook Highlights Cardinal, Becton and The Cooper

2026-04-22
Cardinal, Becton and The Cooper have been highlighted in this Industry Outlook article.

Here Are 3 Medical Supply Stocks to Consider Amid Rising Prospects

2026-04-20
Here, we highlight three dental supplies stocks, CAH, COO and BDX, which are well positioned to generate wealth for investors amid macro uncertainty.

What You Need to Know Ahead of Becton, Dickinson and Company's Earnings Release

2026-04-20
Becton, Dickinson and Company is set to report its fiscal second-quarter earnings next month, and analysts project a double-digit earnings decline.

Becton, Dickinson: Value Or Overvalued Even Now?

2026-04-20

Becton Dickinson Wins Supply Chain Honors As Valuation Appears Undemanding

2026-04-19
Becton Dickinson (NYSE:BDX) has received multi category recognition from the Healthcare Industry Resilience Collaborative for supply chain resilience and transparency. The company reported new clinical findings for the PureWick Urine Collection System indicating improved patient outcomes. BD introduced the Liverty TIPS Stent Graft for portal hypertension, expanding its interventional liver therapy offerings. Becton Dickinson operates across medical devices, diagnostics, and interventional...